| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 137, 617-628, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
P Gaulard, P Bourquelot, P Kanavaros, C Haioun, JP Le Couedic, M Divine, M Goossens, ES Zafrani, JP Farcet and F Reyes
Department of Tissular and Cellular Pathology, Henri Mondor Hospital, Creteil, France.
Fifty-seven cases of peripheral T-cell lymphoma were studied for cell expression of the T-cell receptor (TCR) chains, using monoclonal antibodies specific for the beta chain (beta F1) of the alpha/beta TCR, and for the delta chain (anti-TCR delta-1) of the gamma/delta TCR. Three different patterns were demonstrated: in 39 cases (69%), the phenotype (CD3+beta F1+TCR delta-1-) was that of most normal T cells. A second pattern was found on six cases (10%), which were of CD3+beta F1- TCR delta-1+ phenotype, and in which DNA analysis showed a clonal rearrangement of the delta locus in the five cases studied. It is suggested that these cases are the neoplastic counterpart of the small subpopulation of normal T cells that express gamma delta receptor. It is of considerable interest that these gamma delta lymphomas had unusual clinicopathologic presentations, as one case corresponded to a lethal midline granuloma and the five others to hepatosplenic lymphomas with a sinusal/sinusoidal infiltration in spleen, marrow, and liver. The fact that the distribution of the neoplastic gamma delta cells in the splenic red pulp resembles that of normal gamma delta cells reinforces the concept of a preferential homing of gamma delta T cells to this tissue. A third pattern (CD3 +/- beta F1-TCR delta-1-) was seen in 12 cases (21%), in which, by contrast to normal post-thymic T cells, no evidence of either alpha beta or gamma delta T cell receptor was found.
This article has been cited by other articles:
 |
|
 |
|
  T. Nagato, H. Kobayashi, K. Kishibe, M. Takahara, T. Ogino, H. Ishii, K. Oikawa, N. Aoki, K. Sato, S. Kimura, et al. Expression of Interleukin-9 in Nasal Natural Killer/T-Cell Lymphoma Cell Lines and Patients Clin. Cancer Res., December 1, 2005; 11(23): 8250 - 8257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Belhadj, F. Reyes, J.-P. Farcet, H. Tilly, C. Bastard, R. Angonin, E. Deconinck, F. Charlotte, V. Leblond, E. Labouyrie, et al. Hepatosplenic {gamma}{delta} T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients Blood, December 15, 2003; 102(13): 4261 - 4269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Oyoshi, H. Nagata, N. Kimura, Y. Zhang, A. Demachi, T. Hara, H. Kanegane, Y. Matsuo, T. Yamaguchi, T. Morio, et al. Preferential Expansion of V{gamma}9-J{gamma}P/V{delta}2-J{delta}3 {gamma}{delta} T Cells in Nasal T-Cell Lymphoma and Chronic Active Epstein-Barr Virus Infection Am. J. Pathol., May 1, 2003; 162(5): 1629 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Saito, Y. Matsuno, R. Tanosaki, T. Watanabe, Y. Kobayashi, and K. Tobinai {gamma}{delta} T-cell neoplasms: a clinicopathological study of 11 cases Ann. Onc., November 1, 2002; 13(11): 1792 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nagata, A. Konno, N. Kimura, Y. Zhang, M. Kimura, A. Demachi, T. Sekine, K. Yamamoto, and N. Shimizu Characterization of novel natural killer (NK)-cell and {gamma}{delta} T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus Blood, February 1, 2001; 97(3): 708 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Przybylski, H. Wu, W. R. Macon, J. Finan, D. G. B. Leonard, R. E. Felgar, J. A. DiGiuseppe, P. C. Nowell, S. H. Swerdlow, M. E. Kadin, et al. Hepatosplenic and Subcutaneous Panniculitis-Like {gamma}/{delta} T Cell Lymphomas Are Derived from Different V{delta} Subsets of {gamma}/{delta} T Lymphocytes J. Mol. Diagn., February 1, 2000; 2(1): 11 - 19. [Abstract] [Full Text]
|
|
|
|
|
|
M.-L. Boulland, V. Meignin, K. Leroy-Viard, C. Copie-Bergman, J. Briere, R. Touitou, P. Kanavaros, and P. Gaulard Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas : Association with Anaplastic Large Cell Lymphomas and Nasal Natural Killer-Cell Lymphomas Am. J. Pathol., October 1, 1998; 153(4): 1229 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gisselbrecht, P. Gaulard, E. Lepage, B. Coiffier, J. Briere, C. Haioun, D. Cazals-Hatem, A. Bosly, L. Xerri, H. Tilly, et al. Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas Blood, July 1, 1998; 92(1): 76 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Arnulf, C. Copie-Bergman, M.-H. Delfau-Larue, A. Lavergne-Slove, J. Bosq, J. Wechsler, M. Wassef, C. Matuchansky, B. Epardeau, M. Stern, et al. Nonhepatosplenic gamma delta T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization Blood, March 1, 1998; 91(5): 1723 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K.C. Chan, V.C. Sin, K.F. Wong, C.S. Ng, W. Y.W. Tsang, C.H. Chan, M.M.C. Cheung, and W.H. Lau Nonnasal Lymphoma Expressing the Natural Killer Cell Marker CD56: A Clinicopathologic Study of 49 Cases of an Uncommon Aggressive Neoplasm Blood, June 15, 1997; 89(12): 4501 - 4513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Non-Hodgkin's Lymphoma Classification Project A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood, June 1, 1997; 89(11): 3909 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yamaguchi, T. Ohno, and K. Kita {gamma}/{delta} T-Cell Lymphoma of the Thyroid Gland N. Engl. J. Med., May 8, 1997; 336(19): 1391 - 1392. [Full Text]
|
|
|
|
|
|
K. E. Salhany, M. Feldman, D. Peritt, and P. C. Nowell Cytotoxic T-Lymphocyte Differentiation and Cytogenetic Alterations in gamma delta Hepatosplenic T-Cell Lymphoma and Posttransplant Lymphoproliferative Disorders Blood, May 1, 1997; 89(9): 3490 - 3490. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
